Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 31.40
0.00 (0.00%)
At close: Aug 26, 2026
Immunocore Holdings Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 430.78 | 400.02 | 310.2 | 249.43 | 174.36 | 36.48 |
Revenue Growth | 20.95% | 28.95% | 24.37% | 43.05% | 377.91% | -11.26% |
Gross Profit Gross Profit Growth | 141.59 | 120.06 | 85.32 | 84.85 | 167.96 | -63.76 |
Operating Income Operating Income Growth | -2.85 | -25.63 | -52.41 | -60.55 | -51.7 | -174.66 |
Net Income Net Income Growth | -18.07 | -35.51 | -51.09 | -55.29 | -52.54 | -180.03 |
Earnings Per Share EPS Growth | -0.36 | -0.71 | -1.02 | -1.13 | -1.15 | -4.24 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 278.68 | 257 | 226.69 | 169.79 | 96.89 | - |
Europe Europe Growth | 134.11 | 131.42 | 73.22 | 67.63 | 42.75 | 4.08 |
International International Growth | 17.98 | 11.6 | 10.08 | 1.32 | 1.05 | - |
Total Total Growth | 430.78 | 400.02 | 309.99 | 238.74 | 140.69 | 4.08 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 880.21 | 864.15 | 820.38 | 442.63 | 402.47 | 322.11 |
Total Debt Total Debt Growth | 434.96 | 436.69 | 432.72 | 85.01 | 81.45 | 86.44 |
Net Cash (Debt) Net Cash Growth | 445.25 | 427.47 | 387.65 | 357.62 | 321.02 | 235.67 |
Net Cash Growth | -0.24% | 10.27% | 8.40% | 11.40% | 36.22% | 162.22% |
Net Cash Per Share Net Cash Per Share Growth | 8.78 | 8.49 | 7.75 | 7.31 | 7.02 | 5.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -34.96 | -10.71 | 26.06 | 2.94 | -49.21 | -143.11 |
Capital Expenditures CapEx Growth | -6.2 | -4.34 | -5.17 | -5.43 | -2.2 | -1.39 |
Free Cash Flow Free Cash Flow Growth | -41.15 | -15.05 | 20.89 | -2.49 | -51.41 | -144.49 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.87% | 30.01% | 27.51% | 34.02% | 96.33% | -174.77% |
Operating Margin | -0.66% | -6.41% | -16.89% | -24.27% | -29.65% | -478.73% |
Pretax Margin | -0.63% | -4.77% | -17.07% | -24.41% | -23.45% | -493.04% |
Profit Margin | -4.20% | -8.88% | -16.47% | -22.17% | -30.14% | -493.45% |
FCF Margin | -9.55% | -3.76% | 6.73% | -1.00% | -29.49% | -396.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | 70.66 | - | - | - |
PS Ratio | 4.35 | 4.39 | 4.76 | 13.54 | 15.68 | 41.15 |